| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| H2RNF6_TAKRU | H2T6J9_TAKRU | ENSTRUP00000001669 | ENSTRUP00000020288 | Leucine zipper, putative tumor suppressor 1. | Uncharacterized protein. | 0.403 |
| H2T6J9_TAKRU | H2RNF6_TAKRU | ENSTRUP00000020288 | ENSTRUP00000001669 | Uncharacterized protein. | Leucine zipper, putative tumor suppressor 1. | 0.403 |
| H2T6J9_TAKRU | LOC101068385 | ENSTRUP00000020288 | ENSTRUP00000077413 | Uncharacterized protein. | Sorting nexin 16. | 0.491 |
| H2T6J9_TAKRU | LOC101068385-2 | ENSTRUP00000020288 | ENSTRUP00000077945 | Uncharacterized protein. | Sorting nexin-16. | 0.491 |
| H2T6J9_TAKRU | LOC101078229 | ENSTRUP00000020288 | ENSTRUP00000007788 | Uncharacterized protein. | Luteinizing hormone, beta polypeptide. | 0.558 |
| H2T6J9_TAKRU | S1PR3 | ENSTRUP00000020288 | ENSTRUP00000051217 | Uncharacterized protein. | Sphingosine 1-phosphate receptor 3; Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). | 0.524 |
| H2T6J9_TAKRU | hmox1 | ENSTRUP00000020288 | ENSTRUP00000061528 | Uncharacterized protein. | Heme oxygenase; Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. | 0.412 |
| H2T6J9_TAKRU | hmox2 | ENSTRUP00000020288 | ENSTRUP00000017173 | Uncharacterized protein. | Heme oxygenase 2b. | 0.412 |
| H2T6J9_TAKRU | mrpl4 | ENSTRUP00000020288 | ENSTRUP00000021382 | Uncharacterized protein. | Mitochondrial ribosomal protein L4. | 0.431 |
| LOC101068385 | H2T6J9_TAKRU | ENSTRUP00000077413 | ENSTRUP00000020288 | Sorting nexin 16. | Uncharacterized protein. | 0.491 |
| LOC101068385-2 | H2T6J9_TAKRU | ENSTRUP00000077945 | ENSTRUP00000020288 | Sorting nexin-16. | Uncharacterized protein. | 0.491 |
| LOC101078229 | H2T6J9_TAKRU | ENSTRUP00000007788 | ENSTRUP00000020288 | Luteinizing hormone, beta polypeptide. | Uncharacterized protein. | 0.558 |
| S1PR3 | H2T6J9_TAKRU | ENSTRUP00000051217 | ENSTRUP00000020288 | Sphingosine 1-phosphate receptor 3; Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). | Uncharacterized protein. | 0.524 |
| hmox1 | H2T6J9_TAKRU | ENSTRUP00000061528 | ENSTRUP00000020288 | Heme oxygenase; Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. | Uncharacterized protein. | 0.412 |
| hmox1 | hmox2 | ENSTRUP00000061528 | ENSTRUP00000017173 | Heme oxygenase; Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. | Heme oxygenase 2b. | 0.953 |
| hmox2 | H2T6J9_TAKRU | ENSTRUP00000017173 | ENSTRUP00000020288 | Heme oxygenase 2b. | Uncharacterized protein. | 0.412 |
| hmox2 | hmox1 | ENSTRUP00000017173 | ENSTRUP00000061528 | Heme oxygenase 2b. | Heme oxygenase; Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. | 0.953 |
| mrpl4 | H2T6J9_TAKRU | ENSTRUP00000021382 | ENSTRUP00000020288 | Mitochondrial ribosomal protein L4. | Uncharacterized protein. | 0.431 |
